From the Editors of Pharmaceutical Executive

You are receiving this email as a subscriber to Pharmaceutical Executive

Interested in Learning About Other Topics' Give us your ideas for a Future Webcast or Podcast

*Webcasts:*
Thursday, December 2, 2010 at 2:00 PM ET; 11:00 AM PT Expediting Clinical Site Initiation and Streamlining Site Monitoring with Digital Signatures Managing the conduct of advanced clinical trials has become a key competitive differentiating factor for companies engaged in the commercialization of innovative medicines. Ensuring speed to market while complying with a growing burden of regulatory compliance requires extensive attention to ways that increase efficiency of the process, often using advanced information tools. In this live web event, we will discuss how one critical but often overlooked aspect of clinical trial and GCP quality and compliance processes - the use of standardized uniform digital based signature technologies - can improve trial performance and ultimately help companies reduce time spans and save money in the long course toward market authorization. Specifically, you will learn how digital signatures within the Clinical ecosystem can: Speed study and site initiations Automate site monitoring reporting Enhance investigator portals (CTMS) Streamline regulatory audits and submissions Create secure, compliant and legally enforceable source electronic records that are recognized by sponsor organizations and regulatory authorities Enable secure document exchange and electronic submissions
» Register Free!	Sponsored by: ARX

Tuesday, December 7, 2010 at 12:00 PM ET; 9:00 AM PT Maximizing Brand Performance by Understanding the Degree of Influence Payers and Patients Have on Rx Dispensing at the Point of Purchase The interplay between patients and payers at the pharmacy counter is a largely unknown space. Patients walk into a pharmacy with a Rx for a particular branded product in hand, but may walk out with either a different branded Rx or a generic, or may even walk out empty handed. The gap is often referred to as 'prescription leakage' and is primarily influenced by payer controls and the behaviors of patients during the point of purchase. As payers and patients continue to exert more influence on Rx performance, it is important to understand the degree of influence each has from a national level down to a local level in order to maximize brand performance. Wolters Kluwer Pharma Solutions will share two use cases on how clients are leveraging ProMetis', the industry's first multi-dimensional data and analytics platform, to uncover new market opportunities, identify 'high-value' practitioners, and improve resource allocation to help execute local level marketing strategies.
» Register Free!	Sponsored by: Wolters Kluwer

ON DEMAND Case Study Webcast: Take the Safe Path to creating ERP Value A new ERP "solution" can be a game changer for your organization, and surprisingly, its selection and implementation may not be as risky as you think. Learn the pitfalls encountered during customer ERP projects, from selection to support, and the actions required to minimize risk, including tips on: gaining and maintaining project support balancing budget, schedule and functionality going "under the covers" of your vendor's application and their implementation methodology determining when and how to implement business process changes
» Register Free!

ON DEMAND Implementing a Comprehensive Aggregate Spend and Disclosure Solution to Ensure Compliance with US and International Regulations Compliance with US laws that require disclosure of promotion, marketing and advertising expenses represent a growing cost and administrative burden for life sciences companies. In addition, anti-bribery laws, such as FCPA, and a trend towards global transparency require companies to think beyond just compliance with US regulations. Join us to discuss the current regulatory environment on promotion disclosure and the growing responsibilities for companies to be more transparent with their promotional expenses. Hear about best practices that your peers implement to ensure effective and compliant processes within their organization and avoid common pitfalls in compliance. And learn about cost effective solutions to ensure uniform compliance with state and aggregate reporting requirement rules, including data collection and analysis, security protections, report distribution and management, and technology applications.
» Register Free!	Sponsored by: Cegedim Relationship Management

Podcasts:

Emerging Pharma Leadership Awards 2010
Pharm Exec’s third annual Emerging Pharma Leadership Awards podcast series addresses a key issue facing the biopharma industry today and asks the hard question of what are the attributes of effective leadership in organizations that have no choice but to adapt to a changing market environment? Join us as ten winners discuss their thoughts on leadership today.

Sponsored by: Cegedim Relationship Management

Trends in Patient Access: How Health Reform, Cost of Care and Stakeholder Response Will Shape Pharmaceutical Product Utilization
Questions abound over the impact that health reform and related measures will have on patients’ ability to receive the medications they want and need. Join us as we discuss what pharmaceutical manufacturers, payers, providers and patients are doing in response to this dynamic healthcare environment.

Sponsored by: AmerisourceBergen Specialty Group

Whitepapers:

Safety Document Exchange in the Global Clinical Research Environment
Serious Adverse Event (SAE) reporting can have severe repercussions both for patient safety and company reputation. By choosing a portal solution from a SaaS provider with state-of-the-art online security features, a sponsor or CRO can maintain real-time distribution and access reports for all documents shared, helping maintain compliance and data privacy.

» View Whitepaper